E10 E11
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. diabetes type 1 or type 2, access to the internet and telephone, 2. positive informed consent, 3. support in the study center at controls after study 4. duration of diabetes at least one year, 5. participation of a treatment and teaching programme,6. not achieve the treatment goal above two quarters: patients with diabetes type 1: HbA1c >=8% and /or >3 not severe hypoglycemia per week and/or 1 or more nocturnal hypoglycemia; patients with diabetes type 2: HbA1c >=8% and / or >1 not severe hypoglycemia per week
Exclusion criteria
Exclusion criteria: 1. not give their informed consent, 2. patients with indication for hospital treatment, 3. patients who are not able to fulfill the technical requirements, 4. patients with depression, 5. patients with severe concomitant diseases, 6. pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c measured at baseline, 3 and 6 months after Randomisation | — |
Secondary
| Measure | Time frame |
|---|---|
| incidence of hypoglycemia will be enquired at baseline, 3 and 6 months after Randomisation, treatment satisfaction will be detect with the DTSQ questionaire at baseline and after 6 months, diabetes dependent quality of life will be detect with the ADDQoL questionaire at baseline and after 6 months, medical costs will be calculated after 6 months | — |
Countries
Germany